Levomine Mini (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol is a synthetic estrogen that binds to estrogen receptors, suppressing the release of luteinising hormone and follicle‑stimulating hormone from the pituitary gland. This suppression prevents the mid‑cycle surge that triggers ovulation, thereby reducing the chance of an egg being released.

The dosing regimen for Levomine Mini is determined by the prescribing clinician. Typically, it is taken as a daily oral tablet following the specific cycle schedule indicated on the product label, but the exact regimen should be confirmed with a qualified healthcare professional.

Levomine Mini is contraindicated during pregnancy because it is intended to prevent conception. If pregnancy occurs, the product should be discontinued. Use while breastfeeding should be discussed with a healthcare provider, as hormonal contraceptives may affect milk production and infant exposure.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levomine Mini contains the standard dose combination of ethinylestradiol and levonorgestrel, which is comparable to many other combined oral contraceptives on the market. Its efficacy, safety profile and side‑effect spectrum are similar to alternative products that use the same hormonal components.

Levomine Mini tablets should be stored at ambient temperature, below 25 °C. Keep them in the original packaging to protect from moisture and light, and store them out of reach of children.

Levomine Mini is taken orally, usually once daily at the same time each day. The tablet is swallowed whole with water and should be started according to the prescribing schedule, often on the first day of the menstrual cycle.

Serious risks include thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, stroke, and myocardial infarction. These events are rare but can be life‑threatening, especially in women with pre‑existing cardiovascular risk factors or who smoke.

Women with a history of blood clots, estrogen‑dependent tumours, uncontrolled hypertension, active liver disease, known pregnancy, or who are breastfeeding should avoid Levomine Mini. Additionally, smokers over the age of 35 are advised not to use combined oral contraceptives.